SCHEMBL5474776

SCHEMBL5474776

C[SiH](C)CCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1842192 0.90 TSHR (0.60)
SCHEMBL3900888 0.82
SCHEMBL24513783 0.72 LMNA (0.44)
Glutarate SCHEMBL27556904 0.72 SLC22A6 (0.85)
Adipic Acid SCHEMBL10388302 0.72 LMNA (0.85)
Adipic Acid SCHEMBL11767551 0.72 LMNA (0.85)
Glutarate SCHEMBL6701735 0.71
Glutarate SCHEMBL7414 0.71
Adipic Acid SCHEMBL2244299 0.71 LMNA (1.00)
Adipic Acid SCHEMBL1330953 0.71 LMNA (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3118277-B1 METHOD FOR PRODUCING SURFACE-MODIFIED SUBSTRATE, METHOD FOR PRODUCING CONJUGATE, NOVEL HYDROSILANE COMPOUND, SURFACE TREATMENT AGENT, SURFACE TREATMENT AGENT KIT, AND SURFACE-MODIFIED SUBSTRATE UNIV KYOTO (JP) 2019-10-23 EP claimed
US-20180200273-A1 Silanol Based Therapeutic Payloads BLINKBIO INC (US) 2018-07-19 US disclosed
US-9931407-B2 Silicon based drug conjugates and methods of using same BLINKBIO, INC. (US) 2018-04-03 US disclosed
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2017-07-20 US disclosed
US-20070090052-A1 Chromatographic stationary phase AGILENT TECHNOLOGIES, INC. 2007-04-26 US disclosed